Changchun Wancheng Bio-Electron Recalls Over 91,000 UTI and Urinalysis Test Strips Due to Inaccuracy Risk
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Changchun Wancheng Bio-Electron Co., Ltd. is recalling 91,366 urinalysis test strips across multiple brands because they were distributed without legal marketing authorization.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on February 18, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, medical-device) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Changchun Wancheng Bio-Electron Co., Ltd. has initiated a voluntary Class II recall of several brands of urinary tract infection (UTI) and urinalysis reagent strips. The recall was issued because the devices, which require a 510(k) clearance, were distributed to U.S. customers before they could be legally marketed. According to the FDA, these devices may produce false or inaccurate diagnostic results when used by laypersons, which could lead to inappropriate medical interventions.
Which Products Are Affected
A total of 91,366 units are affected by this recall. The products were distributed nationwide, specifically in Texas, Georgia, and California. Affected brands and lot numbers include:
- LotFancy Urinary Tract Infection Urine (UTI) Test Strips: Lot 2025062001 (Exp: 06/19/2027)
- LotFancy URS-3N Test Strip: Lots 2025033101, 2025080801, 2025090844
- PALINOIA UTI-10 Parameter Reagent Strips: Lots 2025042110, 2025021001
- Vaunn Medical 8-in-1 Urinalysis Reagent Strip: Lots 2024032508, 2024071602, 2024102108
- JNW Direct 4-in-1 UTI Urinalysis Test Strips: Lots 30D25WC, 02D25WC, 30E25WC, 10H24WC
- Urinify STRENGTH: Lots 202403103-6, 202504103-6, 202505103-6, 202504103-3, 202505103-3
- Urinify ESSENTIAL: Lots 202403104-6, 202504104-6, 202505104-6, 202504104-3, 202505104-3
- Urinify Urinary Tract Infection (UTI): Lot 202501105-5
What You Should Do
Consumers who have purchased these products should stop using them immediately. The firm initiated the recall via notification letters on November 22, 2025. Users should contact the place of purchase or the recalling firm, Changchun Wancheng Bio-Electron Co., Ltd., for instructions regarding the disposal or return of the affected test strips.
Why This Matters
The use of unauthorized medical diagnostic tools poses a risk of incorrect self-diagnosis. Inaccurate results could cause a consumer to seek unnecessary medical treatment or fail to seek necessary care for a legitimate health condition.
Source
Information provided by the FDA under recall number Z-1257-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category